Developer docs
API playgroundTry for free, no card

Search company profiles

Olive Tree Capital

Full company profile

uuid0006rsn

Namestring
Olive Tree Capital
Legal namestring
Olive Tree Capital
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital investing, growth equity funding, private equity capital, technology startup investment, life sciences venture capital
Industry1 code
PRIMARYFSAAALAG
Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure)
Financial & Insurance/Asset & Wealth Management/Asset Management — ESG/Sustainable & Impact Investing
NAICS code1 code
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeLicensing Royalties
Description

Olive Tree Capital generates returns through traditional venture capital mechanisms including management fees on committed capital and carried interest from successful portfolio company exits.

olivetreecapital.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Olive Tree Capital is a private venture capital firm that deploys capital across asset classes and managed funds with a focus on private growth equity, investing in early-stage to growth-stage technology and life sciences companies. The firm provides strategic capital, operational expertise, and network access to portfolio companies, targeting breakthroughs across AI/ML, fintech, blockchain, enterprise software, healthcare, and frontier technologies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Olive Tree Capital is a venture capital firm that invests in groundbreaking technology and life sciences companies. The firm does not offer a unified product platform; rather, it provides investment capital and strategic support to a portfolio of independent portfolio companies across sectors including healthcare, life sciences, financial technologies, AI/ML, blockchain, and frontier technologies. Olive Tree Capital's portfolio includes over 80 companies such as Affini-T, Anoma, Array Labs, Phoenix Tailings, MaverickX, Flick, and others, representing the firm's investment focus rather than a product portfolio.

Product and service1 record
1Private growth equity investment capital
CategoryVenture capital investment
Description

Venture and growth equity capital deployed by Olive Tree Capital into early-stage to growth-stage technology and life sciences companies through managed funds, with terms negotiated individually with portfolio companies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Boston-based early-stage life sciences venture firm. Highly comparable geography (Boston) and life sciences investment focus to Olive Tree Capital.

TypeDirect peer
Description

Early-to-growth stage VC investing in technology and life sciences with a science-forward thesis. Highly comparable to Olive Tree Capital's tech and life sciences focus and stage mix.

TypeBroad incumbent
Description

Large, established venture firm with deep exposure to both technology and life sciences across stages. Comparable investment scope to Olive Tree Capital but at much larger scale.

TypeDirect peer
Description

Boston-based early-stage venture firm investing in technology and healthcare. Directly comparable geography, stage, and sector mix to Olive Tree Capital.

TypeBroad incumbent
Description

Established venture firm focused on transformative technology companies across stages. Comparable tech-heavy mandate to Olive Tree Capital though at materially larger scale.

TypeBroad incumbent
Description

Boston-based venture firm investing across technology and healthcare at multiple stages. Comparable Boston footprint and tech/life sciences mandate.

TypeDirect peer
Description

Early-stage venture firm with a strong founder-first orientation and seed/Series A focus. Comparable stage focus and founder-first philosophy to Olive Tree Capital.

TypeDirect peer
Description

Early-stage venture firm investing across consumer, enterprise, and fintech. Comparable stage focus and thematic diversity to Olive Tree Capital's portfolio.

TypeBroad incumbent
Description

Major multi-stage venture firm with broad technology and life sciences coverage. Comparable sector mandate but at dramatically larger scale and brand recognition.

TypeBroad incumbent
Description

Long-standing venture firm with technology and healthcare coverage across stages. Comparable sector mandate though at far larger fund scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment68 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Olive Tree Capital

Venture Capitalolivetreecapital.com

Olive Tree Capital firmographics

Firmographics
Name
Olive Tree Capital
Legal name
Olive Tree Capital
Website
https://olivetreecapital.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Olive Tree Capital industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSAAALAG
Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure)
Financial & Insurance/Asset & Wealth Management/Asset Management — ESG/Sustainable & Impact Investing

Keywords

  • Venture capital investing
  • Growth equity funding
  • Private equity capital
  • Technology startup investment
  • Life sciences venture capital

Where Olive Tree Capital is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

Olive Tree Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Returns: Olive Tree Capital generates returns through traditional venture capital mechanisms including management fees on committed capital and carried interest from successful portfolio company exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Olive Tree Capital product offering

Product offering

Core offering

Olive Tree Capital is a private venture capital firm that deploys capital across asset classes and managed funds with a focus on private growth equity, investing in early-stage to growth-stage technology and life sciences companies. The firm provides strategic capital, operational expertise, and network access to portfolio companies, targeting breakthroughs across AI/ML, fintech, blockchain, enterprise software, healthcare, and frontier technologies.

Product overview

Olive Tree Capital is a venture capital firm that invests in groundbreaking technology and life sciences companies. The firm does not offer a unified product platform; rather, it provides investment capital and strategic support to a portfolio of independent portfolio companies across sectors including healthcare, life sciences, financial technologies, AI/ML, blockchain, and frontier technologies. Olive Tree Capital's portfolio includes over 80 companies such as Affini-T, Anoma, Array Labs, Phoenix Tailings, MaverickX, Flick, and others, representing the firm's investment focus rather than a product portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private growth equity investment capital Venture and growth equity capital deployed by Olive Tree Capital into early-stage to growth-stage technology and life sciences companies through managed funds, with terms negotiated individually with portfolio companies.

Companies that use Olive Tree Capital

Customer profile

Segments2 records

Ideal customer profiles2 records

Olive Tree Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Olive Tree Capital partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Olive Tree Capital competitors and assessment

Company assessment

Direct peers

  • Atlas Venture: Boston-based early-stage life sciences venture firm. Highly comparable geography (Boston) and life sciences investment focus to Olive Tree Capital.
  • Lux Capital: Early-to-growth stage VC investing in technology and life sciences with a science-forward thesis. Highly comparable to Olive Tree Capital's tech and life sciences focus and stage mix.
  • .406 Ventures: Boston-based early-stage venture firm investing in technology and healthcare. Directly comparable geography, stage, and sector mix to Olive Tree Capital.
  • First Round Capital: Early-stage venture firm with a strong founder-first orientation and seed/Series A focus. Comparable stage focus and founder-first philosophy to Olive Tree Capital.
  • Lerer Hippeau: Early-stage venture firm investing across consumer, enterprise, and fintech. Comparable stage focus and thematic diversity to Olive Tree Capital's portfolio.

Broad incumbents

  • Khosla Ventures: Large, established venture firm with deep exposure to both technology and life sciences across stages. Comparable investment scope to Olive Tree Capital but at much larger scale.
  • Founders Fund: Established venture firm focused on transformative technology companies across stages. Comparable tech-heavy mandate to Olive Tree Capital though at materially larger scale.
  • General Catalyst: Boston-based venture firm investing across technology and healthcare at multiple stages. Comparable Boston footprint and tech/life sciences mandate.
  • Andreessen Horowitz: Major multi-stage venture firm with broad technology and life sciences coverage. Comparable sector mandate but at dramatically larger scale and brand recognition.
  • Bessemer Venture Partners: Long-standing venture firm with technology and healthcare coverage across stages. Comparable sector mandate though at far larger fund scale.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Olive Tree Capital social profiles

Digital presence

Olive Tree Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Olive Tree Capital leadership team

Management profile

Number of profiles

Profiles5 records

Olive Tree Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Olive Tree Capital M&A and investment

M&A and investment

M&A

Investments68 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Olive Tree Capital

What does Olive Tree Capital do?

Olive Tree Capital is a private venture capital firm that deploys capital across asset classes and managed funds with a focus on private growth equity, investing in early-stage to growth-stage technology and life sciences companies. The firm provides strategic capital, operational expertise, and network access to portfolio companies, targeting breakthroughs across AI/ML, fintech, blockchain, enterprise software, healthcare, and frontier technologies.

Is Olive Tree Capital a public or private company?

Olive Tree Capital is a private company. It is classified as unknown and is currently operating.

When was Olive Tree Capital founded?

Olive Tree Capital was founded in 2013. It employs 1 to 10 people.

Where is Olive Tree Capital based?

Olive Tree Capital is headquartered in Boston, United States, in the North America region.

How does Olive Tree Capital make money?

One revenue line is on record: venture Capital Returns.

Who are Olive Tree Capital's main competitors?

Direct peers on record are Atlas Venture, Lux Capital, .406 Ventures, First Round Capital and Lerer Hippeau. Broad incumbents are Khosla Ventures, Founders Fund, General Catalyst, Andreessen Horowitz and Bessemer Venture Partners.

Does Olive Tree Capital have an API?

No public API is recorded for Olive Tree Capital.

What industry is Olive Tree Capital in?

Olive Tree Capital's product category is Venture Capital. Its primary akta.pro industry code is FSAAALAG, Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure). Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioWorldRinascera launches with two rare genetic skin disease therapiesRinascera Therapeutics secured initial funding to acquire two drugs for rare genetic skin diseases, despite stalled development with previous owners. The company, incubated by Olive Tree Capital, was named after the Latin root renasci.The SaaS NewsFlick Raises $6M Seed RoundFlick, an AI-native filmmaking platform, raised $6 million in seed funding in May 2026. The round included investments from True Ventures, GV, Y Combinator, Lightspeed, and others. The company will use the funds to accelerate product development and expand its cinematic creative tooling.FinSMEsFlick Raises $6M Seed FundingFlick, an AI-native filmmaking platform, raised $6M in seed funding from True Ventures, GV, Y Combinator, and others. The company will use the funds to accelerate product development, expand creative tooling, and grow its filmmaker community. Founded by Zoey Zhang and Ray Wang, Flick also runs a residency program for new filmmakers.AETOSWireFlick Raises $6M Seed Round to Redefine How AI Films Are CreatedFlick, an AI-native filmmaking platform, raised $6 million in a seed round from True Ventures, GV, Y Combinator, and others. The company will use the funds to accelerate product development and launch Flick Filmmaker Residency, debuting with 10+ short AI-native films at Cinequest, MIT, and Omni AI film festival.Venture Capital Access OnlineFlick Raises $6M Seed Round to Redefine How AI Films Are CreatedFlick, an AI-native filmmaking platform founded by Zoey Zhang and Ray Wang, raised $6 million in a seed round from True Ventures, GV, Y Combinator, and others. The company will use the funds to accelerate product development and launch a filmmaker residency program. The platform aims to give filmmakers cinematic control through AI tools.GlobeNewswireEric Herrera Named to Forbes 30 Under 30 for Driving Innovation in Critical Element Extraction Across Energy and Industrial SectorsMaverickX Co-Founder and CEO Eric Herrera has been named to the Forbes 30 Under 30 Class of 2026 in the Energy & Green Tech category, recognizing his pioneering work in developing solutions for efficient extraction of critical elements and rare earths across oil & gas, mining, agriculture, and industrial sectors. The company, founded in 2022, has developed proprietary LithX and PetroX solutions leveraging bio-inspired chemistry to recover metals from complex environments including drilling fluids, tailings, and industrial waste streams. MaverickX has secured $19 million in Seed funding led by Olive Tree Capital with participation from Y Combinator, and its technology is being deployed in oilfield, mining, and refining operations.The Times of India10club Funding: 10club set to close $30 mn funding round led by Olive Tree Capital - The Economic TimesRoll-up commerce startup 10club is set to close a $30 million funding round led by Olive Tree Capital, with existing investors including Fireside Ventures and Aman Gupta also participating. The company plans to use the capital to expand into the US market and launch new export verticals targeting the Middle East and North Africa regions. This expansion supports 10club's strategy of acquiring and operating brands in fragmented home and fitness categories within India.The Times of IndiaJanani.Life Funding: Healthcare firm Janani.life raises $2.2 million from Y Combinator, Olive Tree Capital among others - The Economic TimesHealthcare firm Janani.life has raised $2.2 million in growth capital from investors including Y Combinator, Olive Tree Capital, and Good Water Capital. The company plans to utilize the funds to expand its technology stack and operations across major cities in India to address lifestyle disorders such as infertility. This funding round follows a previous seed investment of $1.5 million raised last year.Bitlybit.ly/3iAMx0lHealthcare platform Janani.life secured $2.2 million in growth capital from Y Combinator, Olive Tree Capital, and Good Water Capital. The funding round highlights investor confidence in the startup's expansion within the healthcare sector.